Journal list menu
Export Citations
Download PDFs
Publication of this supplement was made possible by the generous support of Dravet Italia Onlus, Biocodex, GW Pharma, Zogenix, Fondazione Cattolica, BPM, Eisai, Nutricia, Sandoz, Ecu-Pharma, and FB Health
Issue Information
Introduction
Free Access
free
Dravet syndrome and other sodium channel-related encephalopathies
- Page: S1
- First Published: 06 January 2020
Supplement Article
Free Access
free
Dravet syndrome as part of the clinical and genetic spectrum of sodium channel epilepsies and encephalopathies
- Pages: S2-S7
- First Published: 06 January 2020
Critical Review and Invited Commentaries
no
Predicting the impact of sodium channel mutations in human brain disease
- Pages: S8-S16
- First Published: 06 January 2020
Supplement Articles
Free Access
free
SCN1A-related phenotypes: Epilepsy and beyond
- Pages: S17-S24
- First Published: 06 January 2020
Free Access
free
SCN1A/NaV1.1 channelopathies: Mechanisms in expression systems, animal models, and human iPSC models
- Pages: S25-S38
- First Published: 06 January 2020
Free Access
free
Dravet syndrome: Treatment options and management of prolonged seizures
- Pages: S39-S48
- First Published: 06 January 2020
Free Access
free
Dravet syndrome: Early electroclinical findings and long-term outcome in adolescents and adults
- Pages: S49-S58
- First Published: 06 January 2020
Free Access
free
Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond
- Pages: S59-S67
- First Published: 06 January 2020
Free Access
free
SCN2A channelopathies: Mechanisms and models
- Pages: S68-S76
- First Published: 06 January 2020
Free Access
free
Phenotypic and genetic spectrum of SCN8A-related disorders, treatment options, and outcomes
- Pages: S77-S85
- First Published: 06 January 2020
Free Access
free
SCN8A encephalopathy: Mechanisms and models
- Pages: S86-S91
- First Published: 06 January 2020